Experienced in Autoimmune Hemolytic Anemia

Dr. Hirohisa Nakamae

Hematology
825 Eastlake Ave E, 
Seattle, WA 
Experienced in Autoimmune Hemolytic Anemia
825 Eastlake Ave E, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hirohisa Nakamae is a Hematologist in Seattle, Washington. Dr. Nakamae is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 300 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Autoimmune Hemolytic Anemia.

Specialties
Hematology
Licenses
Internal Medicine in WA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

825 Eastlake Ave E, Seattle, WA 98109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: May 01, 2025
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2
A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy
A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

300 Total Publications

Efficacy of ibrutinib and diagnostic liver biopsy for idiopathic refractory ascites after allogeneic stem cell transplantation.
Efficacy of ibrutinib and diagnostic liver biopsy for idiopathic refractory ascites after allogeneic stem cell transplantation.
Journal: International journal of hematology
Published: June 08, 2025
Similar Doctors
Distinguished in Autoimmune Hemolytic Anemia
Dr. Steven S. Ginsberg
Hematology Oncology | Oncology | Hematology
Distinguished in Autoimmune Hemolytic Anemia
Dr. Steven S. Ginsberg
Hematology Oncology | Oncology | Hematology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (0.1 miles away)
206-288-1000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Ginsberg is a Hematologist Oncology specialist and an Oncologist in Seattle, Washington. Dr. Ginsberg is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Autoimmune Hemolytic Anemia, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Colorectal Cancer. Dr. Ginsberg is currently accepting new patients.

Distinguished in Autoimmune Hemolytic Anemia
Dr. Paul S. Martin
Hematology Oncology | Hematology | Oncology
Distinguished in Autoimmune Hemolytic Anemia
Dr. Paul S. Martin
Hematology Oncology | Hematology | Oncology

The Association Of University Physicians

1550 N 115th St, 
Seattle, WA 
 (6.1 miles away)
206-364-0500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Paul Martin is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Autoimmune Hemolytic Anemia, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Martin is currently accepting new patients.

Advanced in Autoimmune Hemolytic Anemia
Dr. Jacob Mathew
Hematology | Oncology
Advanced in Autoimmune Hemolytic Anemia
Dr. Jacob Mathew
Hematology | Oncology

Franciscan Medical Group

2720 Clare Ave, Suite A, 
Bremerton, WA 
 (14.2 miles away)
360-479-6154
Languages Spoken:
English, Farsi, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Jacob Mathew is a Hematologist and an Oncologist in Bremerton, Washington. Dr. Mathew is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Pleuropulmonary Blastoma, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Mathew is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nakamae's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 10 Advanced Conditions
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile